# Sanofi partners with Axxam for CNS drug optimization

Sanofi will work with Axxam, an Italian contract research organization, to optimize small molecules targeting central nervous system diseases.

- Type: Partnership
- Announced: 2017-09-11
- Where: Italy
- Status: announced
- Products: small molecules for CNS diseases
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sanofi](https://endata.com/companies/10465.md)
- [Axxam](https://endata.com/companies/26871.md) (partner)

## Sources

- [cen.acs.org](https://cen.acs.org/articles/95/i36/Business-Roundup.html), 2017-09-11: "Sanofi will work with Axxam, an Italian contract research organization, to optimize small molecules targeting a range of central nervous system diseases."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.